Guardant Health, Inc.
GH
$35.84
-$3.48-8.85%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 739.02M | 692.26M | 643.81M | 603.73M | 563.95M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 739.02M | 692.26M | 643.81M | 603.73M | 563.95M |
| Cost of Revenue | 289.80M | 274.72M | 257.85M | 239.28M | 227.05M |
| Gross Profit | 449.22M | 417.53M | 385.96M | 364.45M | 336.90M |
| SG&A Expenses | 545.18M | 504.80M | 463.02M | 453.24M | 450.73M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.18B | 1.12B | 1.07B | 1.05B | 1.04B |
| Operating Income | -443.71M | -431.33M | -427.67M | -446.65M | -481.03M |
| Income Before Tax | -435.09M | -512.38M | -490.27M | -460.05M | -478.76M |
| Income Tax Expenses | 1.28M | 27.00K | 487.00K | 850.00K | 685.00K |
| Earnings from Continuing Operations | -436.37 | -512.41 | -490.76 | -460.90 | -479.45 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -436.37M | -512.41M | -490.76M | -460.90M | -479.45M |
| EBIT | -443.71M | -431.33M | -427.67M | -446.65M | -481.03M |
| EBITDA | -401.33M | -388.53M | -384.43M | -403.41M | -438.14M |
| EPS Basic | -3.56 | -4.24 | -4.09 | -3.92 | -4.28 |
| Normalized Basic EPS | -2.15 | -2.10 | -2.10 | -2.15 | -2.51 |
| EPS Diluted | -3.56 | -4.24 | -4.09 | -3.92 | -4.28 |
| Normalized Diluted EPS | -2.15 | -2.10 | -2.10 | -2.15 | -2.51 |
| Average Basic Shares Outstanding | 490.96M | 485.72M | 480.40M | 466.76M | 447.72M |
| Average Diluted Shares Outstanding | 490.96M | 485.72M | 480.40M | 466.76M | 447.72M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
